MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Borrowings History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Short Term Borrowings | ₹2,513 Cr | ₹151 Cr | ₹115 Cr | ₹795 Cr | ₹158 Cr |
What is the latest Short Term Borrowings ratio of MANKIND PHARMA ?
Year | Short Term Borrowings |
---|---|
Mar2025 | ₹2,513 Cr |
Mar2024 | ₹151 Cr |
Mar2023 | ₹115 Cr |
Mar2022 | ₹795 Cr |
Mar2021 | ₹158 Cr |
How is Short Term Borrowings of MANKIND PHARMA Trending?
Years | Short Term Borrowings | % Change | |
---|---|---|---|
Mar2025 | ₹2,513 Cr | 1,559.06 | |
Mar2024 | ₹151 Cr | 31.70 | |
Mar2023 | ₹115 Cr | -85.52 | |
Mar2022 | ₹795 Cr | 401.78 | |
Mar2021 | ₹158 Cr | - |
Compare Short Term Borrowings of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹101,767.7 Cr | -6.2% | -3.1% | 23.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -6.2% |
-3.1% |
23.6% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses